Thursday, 5 November 2026European Markets

ITERA And ASM INTERNATIONAL Have A High Dividend Yield And Return On Equity In The Technology Sector.

Loading stream...

(VIANEWS) - ITERA (ITERA.OL) is among this list of stock assets with the highest dividend rate and return on equity on the Technology sector.

Financial Asset Price Forward Dividend Yield Return on Equity
ITERA (ITERA.OL) kr11.25 3.54% 63.44%
ASM INTERNATIONAL (ASM.AS) €573.40 0.49% 17.12%

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. ITERA (ITERA.OL)

3.54% Forward Dividend Yield and 63.44% Return On Equity

Itera ASA, together with its subsidiaries, develops and operates digital solutions for businesses and organizations in Norway, Sweden, Ukraine, Denmark, Czech Republic, Iceland, Poland, and Slovakia. It offers data, artificial intelligence and analytics, development and architecture, test and quality assurance solutions, as well as cloud and application services. The company provides a range of services in the strategy and consulting, customer experience, and technology and cloud transformation areas. It serves banking and insurance, energy and utilities, industry and manufacturing, health and public services, technology and communication, and products and retail industries. The company was founded in 1989 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, ITERA has a trailing twelve months EPS of kr0.57.

PE Ratio

ITERA has a trailing twelve months price to earnings ratio of 19.74. Meaning, the purchaser of the share is investing kr19.74 for every norwegian krone of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 63.44%.

Moving Average

ITERA's value is below its 50-day moving average of kr11.48 and below its 200-day moving average of kr11.83.

More news about ITERA.

2. ASM INTERNATIONAL (ASM.AS)

0.49% Forward Dividend Yield and 17.12% Return On Equity

ASM International NV, together with its subsidiaries, engages in the research, development, manufacture, marketing, and servicing of equipment and materials used to produce semiconductor devices in Europe, the United States, and Asia. The company's products include wafer processing deposition systems for atomic layer deposition (ALD), epitaxy, silicon carbide, plasma enhanced chemical vapor deposition (PECVD), and vertical furnace systems, including low pressure chemical vapor deposition (LPCVD), diffusion, and oxidation products, as well as provides spare parts and support services. It also manufactures and sells equipment, which is used in wafer processing, encompassing the fabrication steps in which silicon wafers are layered with semiconductor devices. The company offers its products to semiconductor manufacturers. The company was formerly known as Advanced Semiconductor Materials International NV. ASM International NV was incorporated in 1968 and is headquartered in Almere, the Netherlands.

Earnings Per Share

As for profitability, ASM INTERNATIONAL has a trailing twelve months EPS of €11.16.

PE Ratio

ASM INTERNATIONAL has a trailing twelve months price to earnings ratio of 51.38. Meaning, the purchaser of the share is investing €51.38 for every euro of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.12%.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on May 15, 2024, the estimated forward annual dividend rate is 2.75 and the estimated forward annual dividend yield is 0.49%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ASM INTERNATIONAL's stock is considered to be oversold (<=20).

More news about ASM INTERNATIONAL.

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,549 source documents archived
Query this data → isubstrate.com